Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VILAVI is a health and wellness company headquartered in Novosibirsk, Russia, specializing in the development and distribution of anti-aging and bio-hacking products. The company's core technology is the SibXP Complex, a proprietary blend of polyprenols, coniferous cell juice, and chlorophyll-carotene paste derived from Siberian fir. VILAVI operates primarily through a network marketing (MLM) business model, offering a range of dietary supplements under the Tayga8 brand designed to optimize mitochondrial health and cellular energy. Their product portfolio includes liquid concentrates, food products, and metabolic health supplements aimed at improving energy levels, cognitive function, and overall longevity. The company has expanded its presence from Russia into the CIS region and international markets, positioning itself as a leader in the mitochondrial health niche.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VILAVI.